Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)-KSNS

ÇмúÇà»ç

·Î±×ÀÎ ¾ÆÀ̵ð ±â¾ï
 
ÇмúÇà»ç¸ñ·Ï Home > ÇмúÇà»ç > ÇмúÇà»ç¸ñ·Ï
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop °³ÃÖ ¾È³»
ÀÛ¼ºÀÚ °ü¸®ÀÚ email http://www.nonclinical.or.kr
Date2019³â 04¿ù 05ÀÏ 14:36Hits6128
÷ºÎÆÄÀÏ Files(746 kb) Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop ÃÊ´ëÀå
Files(352 kb) Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop °³ÃÖ ¾È³»
Files(8724 kb) Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop ¸®Ç÷¿

Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop °³ÃÖ ¾È³»
"Connecting the Dots in Drug Discovery"
2019³â 5¿ù 23ÀÏ(¸ñ) 09:00~17:40 / °æ±â°æÁ¦°úÇÐÁøÈï¿ø °æ±âȦ



1. ±Í»çÀÇ ¹«±ÃÇÑ ¹ßÀü°ú ±ÍÇÏÀÇ °Ç½ÂÇϽÉÀ» ±â¿øÇÕ´Ï´Ù.
2. Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸¿¡¼­´Â Á¦35Â÷ ¿öÅ©¼¥À» "Connecting the Dots in Drug Discovery" À̶ó´Â ÁÖÁ¦·Î ´ÙÀ½°ú °°ÀÌ °³ÃÖÇÏ¿À´Ï, ȸ¿ø ¿©·¯ºÐÀÇ ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.
3. ÃÑȸ¿¡¼­ Á¤°ü °³Á¤¿¡ ´ëÇÑ ½ÉÀÇ ¹× ÀǰáÀÌ ÀÖÀ» ¿¹Á¤ÀÌ¿À´Ï ȸ¿øºÐµéÀº ¸ðµÎ Âü¼®ÇØÁֽñ⠹ٶø´Ï´Ù.


¡á Çà»ç°³¿ä

Çà»ç¸í Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019³â Á¦35Â÷ Workshop
ÁÖÁ¦ Connecting the Dots in Drug Discovery
ÀϽà 2019³â 5¿ù 23ÀÏ(¸ñ) 09:00~17:40
Àå¼Ò °æ±â°æÁ¦°úÇÐÁøÈï¿ø °æ±âȦ (±¸, °æ±âÁß¼Ò±â¾÷Áö¿ø¼¾ÅÍ) ÀÚ¼¼È÷ º¸±â
ÁÖ¼Ò : °æ±âµµ ¼ö¿ø½Ã ¿µÅ뱸 ±¤±³·Î 107
»çÀüµî·Ï±â°£ 2019³â 4¿ù 10ÀÏ (¼ö) ~ 5¿ù 17ÀÏ (±Ý)
1) ȨÆäÀÌÁö (www.nonclinical.or.kr)³» Á¦35Â÷ ¿öÅ©¼¥ »çÀüµî·Ï ¸Þ´º ÀÌ¿ë
2) ºñȸ¿øÀº ȸ¿ø°¡ÀÔ ÈÄ µî·Ï °¡´É
µî·Ïºñ »çÀüµî·Ï 5¸¸¿ø(Çлý 2¸¸¿ø), ÇöÀåµî·Ï 7¸¸¿ø(Çлý 4¸¸¿ø)
1) »çÀüµî·Ï Ä«µå°áÁ¦ °¡´É.(Ä«µå°áÁ¦ ½Ã ¼¼±Ý°è»ê¼­ ¹ßÇàºÒ°¡)
2) ÀÚ·áÁý, ¼ö·áÁõ, Áᫎ Æ÷ÇÔ
3) ¼¼±Ý°è»ê¼­ ¹ß±Þ (ÀÔ±ÝÀÏ ±âÁØ 1ȸ ¹ß±Þ)ÀÌ ÇÊ¿äÇϽŠºÐÀº »ç¾÷ÀÚµî·ÏÁõ ÷ºÎ ¿ä¸Á
4) ÇöÀåµî·ÏÀÇ °æ¿ì, ¼¼±Ý°è»ê¼­ ¹ß±Þ ºÒ°¡, ¿¬±¸È¸ ÀÚü ¿µ¼öÁõ ¹ß±Þ
5) ÀԱݰèÁÂ: ¿ì¸®ÀºÇà 1005-403-436526 ¢ßµå¸²ÆÄÆ®³Ê Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸
6) ÀԱݸ¶°¨: 2019³â 5¿ù 17ÀÏ(±Ý), ÀÔ±Ý ½Ã ¼Ò¼Ó, ¼º¸í ±âÀÔ ¿ä¸Á
°ü·Ã°ø¹® °ø¹® - Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019 Á¦35Â÷ Workshop °³ÃÖ ¾È³» °ø¹® - Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019 Á¦35Â÷ Workshop °³ÃÖ ¾È³»
¸®Ç÷¿ - Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019 Á¦35Â÷ Workshop ¸®Ç÷¿ - Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ 2019 Á¦35Â÷ Workshop °³ÃÖ ¾È³»
¹®ÀÇ ±âŸ ¹®ÀÇ»çÇ×Àº Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
KSNS »ç¹«±¹ : Tel. 031-702-9123 / E-mail. ksns@nonclinical.or.kr / ´ã´çÀÚ. ±èÁذï


¡á µî·Ï¾È³»

- »çÀüµî·Ï ¾È³»

µî·Ï±â°£ 2019³â 4¿ù 10ÀÏ (¼ö) ~ 5¿ù 17ÀÏ (±Ý)
µî·Ï¹æ¹ý - ¿¬±¸È¸ ȨÆäÀÌÁö (www.nonclinical.or.kr) ÇмúÇà»ç >»çÀüµî·Ï ¸Þ´º ÀÌ¿ë
- ºñȸ¿øÀº ȸ¿ø°¡ÀÔ ÈÄ, »çÀüµî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.

- µî·Ïºñ <Áß¿ä°øÁö >Ä«µå°áÁ¦ °¡´É

µî·Ïºñ ±¸ºÐ »çÀüµî·Ï ÇöÀåµî·Ï
Á¤È¸¿ø 50,000¿ø 70,000¿ø
Çлýȸ¿ø 20,000¿ø 40,000¿ø
• »çÀüµî·Ïºñ : ÀÚ·áÁý, ¼ö·áÁõ, Áᫎ Æ÷ÇÔ
¼¼±Ý°è»ê¼­ ¹ß±Þ(ÀÔ±ÝÀÏ ±âÁØ 1ȸ ¹ß±Þ)ÀÌ ÇÊ¿äÇÒ °æ¿ì, ¿Â¶óÀÎ µî·Ï ½Ã ¼¼±Ý°è»ê¼­ ¹ßÇà¿©ºÎ¸¦ üũÇϰí, »ç¾÷ÀÚµî·ÏÁõ »çº»À» ¹Ýµå½Ã ÷ºÎ
ÇöÀåµî·Ï ¹× Çлýµî·ÏÀÇ °æ¿ì, ¼¼±Ý°è»ê¼­ ¹ß±Þ ºÒ°¡, ¿¬±¸È¸ ÀÚü ¿µ¼öÁõ ¹ß±Þ

- ¹«ÅëÀåÀÔ±Ý (°èÁÂÀÌü)

ÀԱݰèÁ ¿ì¸®ÀºÇà 1005-403-436526 ¢ßµå¸²ÆÄÆ®³Ê Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸
ÀԱݰèÁ ~ 2019³â 5¿ù 17ÀÏ (±Ý) 18½Ã ±îÁö
ÀԱݽà ¹Ýµå½Ã "¼Ò¼Ó/¼º¸í" À» ±âÀÔÇϼ¼¿ä.
• ¹«ÅëÀå ÀÔ±Ý(°èÁÂÀÌü)ÀÌü ÈÄ, »ç¹«±¹¿¡¼­ ÀÔ±ÝÀ» È®ÀÎÇÏ´Â ½Ã°£ÀÌ ÇÊ¿ä ÇÕ´Ï´Ù.
• ±âŸ µî·Ï °ü·Ã ¹®ÀÇ»çÇ×Àº Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ »ç¹«±¹À¸·Î ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
   TEL. 031-702-9123 / E-mail. ksns@nonclinical.or.kr, ±èÁذï


¡á ÇÁ·Î±×·¥ ¾È³»

  • ÀϽà : 2019³â 5¿ù 23ÀÏ(¸ñ) 09:00~17:40
  • Àå¼Ò : °æ±â°æÁ¦°úÇÐÁøÈï¿ø °æ±âȦ(°æ±âµµ ¼ö¿ø½Ã ¿µÅ뱸 ±¤±³·Î 107)
  • ÁÖÁ¦ : Connecting the Dots in Drug Discovery

½Ã°£ ÇÁ·Î±×·¥
09:00~09:40 µî·Ï
09:40~09:50 °³ ȸ »ç (ȸÀå, ¿À¼¼¿õ)
09:50~10:00 Ãà»ç (´ëÇѾàÇÐȸÀå, À̿뺹)
Session 1 Plenary
10:00~10:40 4Â÷ »ê¾÷Çõ¸í°ú Á¦¾à¡¤¹ÙÀÌ¿À ±â¼ú¸¶ÄÉÆÃ ÇöȲ°ú Àü·«
(4th Industrial Revolution and Current Status and Strategy of Pharma-Bioceutical Licensing)
Á¶ÇåÁ¦
Çѱ¹½Å¾à°³¹ß¿¬±¸Á¶ÇÕ
Session 2 Platform
10:40~11:20 Novel Hit Discovery using DNA Encoded Library Technology DengFeng Dou
HITGEN
11:20~12:00 Development of Innovative Therapeutics Using BioDrone Platform Based on Cell-Derived Vesicles ¹è½Å±Ô
¿¥µð¹Ã
12:00~13:30 Luncheon Symposium & Booth Exhibition
Session 3-1 µ¶¼ººÐ°ú
13:30~14:10 How To Survive Critical Adverse Data Christopher Stewart
SGI Consulting, LLC.
14:10~14:50 Safety of the Stem Cell Therapy Á¶½ÂÁÖ
KBIOHEALTH
14:50~15:30 Developing CARs-based T Cell Adoptive Immunotherapy Enrico Pesenti
Accelera srl
Session 3-2 ¾àµ¿ºÐ°ú
13:30~14:10 »ý¹°ÀǾàǰ °³¹ß ½Ã °í·ÁÇØ¾ß ÇÒ ¾àµ¿ÇÐÀû Ư¼º
(Pharmacokinetic Properties to Consider for Developing Biologics)
À±ÈÖ¿­
Ãæ³²´ë
14:10~14:50 ÀÓ»ó °³¹ß Áß ºñÀÓ»ó °á°ú¸¦ °í·ÁÇÑ ÀÇ»ç °áÁ¤
(Decision Marking Considering Non-Clinical Results for Clinial Development)
ÇѽÂÈÆ
¼­¿ï¼º¸ðº´¿ø
14:50~15:30 Translational models of obesity, dysmetabolism, diabetes & complications: Nephropathy, NASH, Cardiomyopathy Jim Wang
Crown Bioscience Inc
Session 3-3 ¾àÈ¿ºÐ°ú / °Ç±¹´ë ¹ÙÀÌ¿ÀÀ̹Ì¡¼¾ÅÍ °øµ¿½ÉÆ÷Áö¿ò
13:30~14:10 ½Ç½Ã°£ ¹ß±¤¿µ»ó±â¼úÀ» ÀÌ¿ëÇÑ Ç׿ì¿ïÁ¦ÀÇ ºÐÀÚ»ý¹°ÇÐÀû ±âÀÛ ±Ô¸í
(Identification of Molecular Mechanisms of Antidepressants Using Bio-Optical Imaging Technology)
Çã¼Û¿í
±âÃʰúÇÐÁö¿ø¿¬±¸¿ø
14:10~14:50 Multi-parametric MRI ½Å¾à°³¹ß ÀÀ¿ë
(Application of Multi-Parametric MRI for New Drug R&D)
ÀÌÀçÁØ
¿À¼Û÷´ÜÀÇ·á»ê¾÷ÁøÈï¿ø
14:50~15:30 ½Å¾à°³¹ß ÀüÀÓ»ó¿¡¼­ ¹æ»ç¼º µ¿À§¿ø¼Ò¸¦ Ȱ¿ëÇÑ »ýü ºÐÀÚ¿µ»ó
(Biomolecular Imaging Using Radioactive Isotopes in Pre-Clinical Development of New Drugs)
ÃÖÀç¿ë
¿øÀÚ·ÂÀÇÇבּ¸¿ø
Session 4 Case study
16:00~16:40 CKD-506 in autoimmune diseases (non-clinical studies) ½ÅÁöÀº
Á¾±Ù´ç
16:40~17:20 Strategies for Biosimilar Development; RemsimaTM ÀüȲ±Ù
¼¿Æ®¸®¿Â
17:20~17:30 ÃÑȸ
17:30~17:50 Æó ȸ »ç ¹× °æÇ° Ãß÷ (ºÎȸÀå, ½ÉÇöÁÖ)
18:00 ~ °£ Ä£ ȸ (Àå¼Ò º°µµ °øÁö)
* »ó±â ÇÁ·Î±×·¥Àº ¿¬ÀÚ ¹× ±âŸ »çÁ¤À¸·Î º¯µ¿ ¼ö ÀÖ½À´Ï´Ù.

¡á ¿À½Ã´Â ±æ

ÁÖ¼Ò °æ±âµµ ¼ö¿ø½Ã ¿µÅ뱸 ±¤±³·Î 107 (Áö¹ø: °æ±âµµ ¼ö¿ø½Ã ¿µÅ뱸 ÀÌÀǵ¿ 906-5)
ȨÆäÀÌÁö °æ±â°æÁ¦°úÇÐÁøÈï¿ø °æ±âȦ (±¸, °æ±âÁß¼Ò±â¾÷Áö¿ø¼¾ÅÍ) ÀÚ¼¼È÷ º¸±â
ÁöÇÏö·Î ¿À½Ã´Â °æ¿ì
  1. ÁöÇÏöÀ» ÀÌ¿ëÇÏ¿© ±¤±³Áß¾Ó¿ª(½ÅºÐ´ç¼±)¿¡¼­ ¿À½Ã´Â °æ¿ì
    (µµº¸) 3¹ø Ãⱸ¿¡¼­ Ⱦ´Üº¸µµ »ï°Å¸®±îÁö À̵¿ÇÏ¿© Ⱦ´Üº¸µµ¸¦ °Ç³Í ÈÄ, ¿ùµåÄŰæ±âÀå ¹æ¸éÀ¸·Î ¾à 500m µµº¸ (¾à 20ºÐ ¼Ò¿ä) (´ëÁß±³Åë) 3¹ø Ãⱸ¿¡¼­ ¾à 300m µµº¸ À̵¿ÇÏ¿© ±¤±³Áß¾Ó¿ª, ±¤±³°íµîÇб³ Á¤·ùÀå¿¡¼­ 88-1¹ø ¶Ç´Â 13-4¹ø ž½Â ÈÄ °æÁ¦°úÇÐÁøÈï¿ø, °æ±âÀÏÀÚ¸®¼¾ÅÍ Á¤·ùÀå ÇÏÂ÷ (¾à 20ºÐ ¼Ò¿ä)
  2. ÁöÇÏöÀ» ÀÌ¿ëÇÏ¿© ¼ö¿ø¿ª(1È£¼±)¿¡¼­ ¿À½Ã´Â °æ¿ì
    9¹øÃⱸ ¸Å»ê½ÃÀå Á¤·ùÀå¿¡¼­ ½ÂÂ÷ (7, 9-2, 13-4, 7202¹ø) °æÁ¦°úÇÐÁøÈï¿ø, °æ±âÀÏÀÚ¸®¼¾ÅÍ Á¤·ùÀå¿¡¼­ ÇÏÂ÷ ÈÄ È¾´Üº¸µµ ¸ÂÀºÆí Á÷Áø 300m µµº¸
  3. ÁöÇÏöÀ» ÀÌ¿ëÇÏ¿© ¼ö¿ø½Ãû¿ª(ºÐ´ç¼±)¿¡¼­ ¿À½Ã´Â °æ¿ì
    9¹øÃⱸ ±¹¹Î¿¬±Ý°ø´Ü Á¤·ùÀå¿¡¼­ ½ÂÂ÷ (85¹ø) °æÁ¦°úÇÐÁøÈï¿ø, °æ±âÀÏÀÚ¸®¼¾ÅÍ Á¤·ùÀå¿¡¼­ ÇÏÂ÷ ÈÄ È¾´Üº¸µµ ¸ÂÀºÆí Á÷Áø 300m µµº¸




List
°³ÀÎÁ¤º¸Ãë±Þ¹æÄ§
(ÁÖ)µå¸²ÆÄÆ®³Ê (»ç¾÷ÀÚµî·Ï¹øÈ£ : 320-88-00843, ´ëÇ¥ : ±è»ó¿ì)
Çѱ¹ºñÀÓ»ó½ÃÇ迬±¸È¸ (The Korean Society Nonclinical Study)
(¿ì)446-982 °æ±âµµ ¿ëÀνà ±âÈﱸ Èï´öÁß¾Ó·Î 120 U-TOWER 1411È£
Tel : 031-702-9123 , Fax : 031-213-9125, E-Mail : ksns@nonclinical.or.kr
Copyright & "The Korean Society Nonclinical Study". Website development and maintenance: "Expedition". All Rights Reserved.